NASDAQ:ARWR
Arrowhead Pharmaceuticals, Inc.
- Stock
locale
United States
market
STOCKSindustry
Biotechnologywebsite
arrowheadpharma.comipo date
Dec 16, 1993
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, which is in phase 2b and one phase...Show More
Earnings
Earnings Release in 9 daysEarnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus